Adverse effect of succinimides and oxazolidinediones, subs

This code signifies a harmful or unintended reaction to medications belonging to the succinimide or oxazolidinedione drug classes, which are primarily used to treat seizure disorders. The "subsequent encounter" designation indicates that the patient is receiving follow-up care for an adverse effect that was initially diagnosed and treated in a previous encounter.

This code is appropriate when a patient presents for ongoing management, monitoring, or treatment related to an adverse effect from succinimide or oxazolidinedione medication. Examples include follow-up appointments for persistent rash, liver enzyme abnormalities, or hematologic issues that developed as a side effect of these antiepileptic drugs.

• Always sequence this code after the code for the specific adverse effect (e.g., rash, hepatitis).
• Ensure documentation clearly states the adverse effect is drug-induced and specifies the drug class.
• Distinguish from initial encounter (A), subsequent encounter (D), and sequela (S) based on the patient's current phase of care.